| Particulars |
|
|
|
| Company Name
| Concord Biotech Ltd
| Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
10.46 |
B.V. (₹) |
152.00 |
| Sales(₹ Cr.) |
1,016.94 |
NP (₹ Cr.) |
294.25 |
| NP Var% |
25.00 |
Div% |
875.00 |
| CPS(₹) |
33.20 |
EPS (₹) |
28.10 |
| Traded Value(₹ Lakhs) |
84.76 |
52 Week High |
2,658.00 |
| 52 Week Low |
1,327.00 |
Price BSE |
1,506.00 |
| Price NSE |
1,506.00 |
Market Capital (₹ Cr.) |
15,756.77 |
| P/C Ratio |
45.30 |
P/E Ratio |
53.50 |
| Price Vs.BV |
9.91 |
|
| Latest Quarter |
| Year End |
202412 |
Sales (₹ Cr.) |
244.22 |
| NP(₹ Cr.) |
74.09 |
NP Var % |
-1.00 |
| Trailing Twelve Months |
| Year End |
202412 |
Sales |
1,085.75 |
| OPM |
42.20 |
NP |
328.71 |
| NP Var% |
9.04 |
EPS |
31.38 |
| PE |
48.00 |
|
|